Karen Krok, MD - Penn State Cancer Institute
Researcher Profile

Karen Krok, MD
Director of Hepatology, Division of Gastroenterology and Hepatology
Research Interests
Dr. Karen Krok joined Penn State College of Medicine in 2013. Her research interests include post-liver-transplant outcomes, focusing on patients transplanted for hepatitis C; the cardiovascular complications of patients after a liver transplant; pulmonary complications of liver disease; and outcomes of heart-liver transplants in the congenital heart disease population.
Dr. Krok is the site PI for a multicenter trial, Pulmonary Vascular Complications of Liver Disease 3 Study Group, which assesses the pulmonary complications and hormonal changes in patients with pulmonary hypertension and hepatopulmonary syndrome. She has successfully recruited for and been the site PI for several multi-site and pharmaceutical clinical trials.
As the congenital heart disease population is aging, there is more evidence of liver disease associated with the Fontan circulation. Dr. Krok has served on an international multi-specialty group that developed recommendations about how to follow these patients clinically.
- Liver Transplantation
- Therapeutics
- Liver Diseases
- Liver
- Fibrosis
- Hepatopulmonary Syndrome
- Survival
- Chronic Disease
- Blood Vessels
- Incidence
- Confidence Intervals
- Crohn Disease